What is CBZ's health score?

CBIZ, Inc. (CBZ) has a TradeApes health score of 59 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is CBZ's estimated fair value?

Based on our 5-year discounted cash flow model, CBIZ, Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is CBZ undervalued or overvalued?

Our model currently rates CBZ as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

3 free score cards remaining

CBIZ, Inc. (CBZ)

Technology Overvalued low mixed

$42.42

Updated: 2026-07-18

TradeApes Score

Financial Strength

45 Mixed

Operating Trend

75 Strong

Relative Value

75 Strong

Capital Allocation

35 Weak

Risk Management

50 Mixed

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− High leverage — net debt/EBITDA between 3× and 5×

Unlock Full Report →

Industry Related Stocks

Accenture plc (ACN) ACV Auctions Inc. (ACVA) Advantage Solutions Inc. (ADV) Akso Health Group (AHG) AKAMAI TECHNOLOGIES INC (AKAM) Alight, Inc. / Delaware (ALIT)

See all Technology stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.